Episode 18: Serotonin, Spirituality & Science: Inside Psychedelics A to Z with Dr Olga Chernoloz

June 30th, 2025  |  1 hr 4 mins

history, lsd, maps, maps canada, mental health, psilocybin, psychedelic, psychedelics, renaissance, research, science, therapy, vancouver

Psychedelics A to Z with Dr. Olga Chernoloz | MAPS Canada Podcast
Join us for an insightful conversation with neuropharmacologist and author Dr. Olga Chernoloz as she breaks down the science, culture, and creativity woven into her beautifully illustrated book, Psychedelics A to Z. We explore key topics like harm reduction, microdosing, cultural use of cannabis, the role of music in transcendental states, and why journaling is essential for integration.

Don’t forget to like, subscribe, and drop your questions in the comments.

PsychedelicsAtoZ #MAPSCanada #PsychedelicTherapy #MentalHealth #Integration #PsychedelicScience #OlgaChernoloz

Episode 19: Ink on Acid: Graphic Novel Reimagining Psychedelic Research | Brian Blomerth

June 28th, 2025  |  48 mins 53 secs

art, creativity, dmt, history, lsd, maps canada, mental health, mental-health, psilocybin, psychedelic, psychedelics, renaissance, research, science, therapy

Dive into the kaleidoscopic mind of illustrator and cartoonist Brian Blomerth as he discusses Lilly Wave, his graphic novel exploration of the brilliant and bizarre life of John C. Lilly. From sensory deprivation tanks to dolphin telepathy and ketamine voyages, Blomerth's hallucinatory visuals and meticulous research reframe the psychedelic era like never before. In this episode, "Ink on Acid," we trace the waves of science, madness, and artistic obsession that ripple through Blomerth’s latest work.

Tune in to explore how graphic storytelling can reshape how we understand radical research.

GraphicNovels #Psychedelics #JohnLilly #VisualStorytelling #BrianBlomerth #Podcast #mapscanada

Episode 23: Psychedelics, Fentanyl & Radical Drug Policy | Mitchell Gomez on Harm Reduction

June 27th, 2025  |  1 hr 34 mins

In this episode of the MAPS Canada podcast, host Osheen sits down with Mitchell Gomez, Executive Director of DanceSafe, to talk about the evolving psychedelic landscape, the rise of fentanyl in recreational drugs, and why harm reduction—not prohibition—is the future of drug policy.
Mitchell shares hard truths from the rave scene, the importance of drug testing, the science behind psychedelic safety, and how law enforcement and public health systems must adapt to the new drug reality.
Key topics include:
-Why DanceSafe was founded
-Fentanyl’s growing threat
-How technology is improving drug testing
-The case for regulated drug sales
-Why LSD is less toxic than water
-The risks and benefits of psychedelics
-Community support and peer education
-The importance of training for psychological crises

Subscribe for more conversations at the intersection of psychedelics, policy, and public health.

PsychedelicMedicine #HarmReduction #DanceSafe #DrugPolicy #FentanylCrisis #Psychedelics #DrugSafety #PublicHealth #MAPSCanada

Episode 17: Cannabis, Opioid Use Disorder & Overdose Prevention: A Harm Reduction Conversation with Dr MJ Milloy

May 1st, 2025  |  1 hr 19 mins

Using Cannabis to Delay Opioid Use: Harm Reduction Strategies for Overdose Prevention with Dr. M-J Milloy

Why isn’t the evidence around supervised injection sites leading to real change? How does cannabis interact with opioid use treatment? In this episode, Dr. M-J Milloy, Interim Director of Research at BCCSU, dives into the data—and the disconnect—between science and policy. We explore gendered and SES experiences of substance use, the link between housing and drug safety, and how research can drive more compassionate public health responses.

Episode 16: Healing & Harm Reduction in Psychedelics: A Conversation with Erica Siegal

April 30th, 2025  |  1 hr 18 mins

mental-health, psychedelics, research, science

How can we make psychedelic healing safer?
In this episode, MAPS Canada's Podcast host, Osheen Dayal, talks with Erica Siegal about the ethics, risks, and realities of psychedelic therapy.
Erica is a licensed therapist, harm reduction expert, and the Executive Director of
SHINE Collective, a nonprofit supporting survivors of harm in psychedelic spaces.

Episode 15: The importance of Set, Setting and Sitter at Psychedelic Clinical Trials

April 29th, 2025  |  1 hr 38 secs

mental-health, psychedelics, research, science

A Psychedelic Clinic Trial Cautionary Tale

Episode 14: How Cannabis Can Act As a Reverse “Gateway Drug” | Dr. Zach Walsh

September 17th, 2024  |  56 mins 18 secs

In this episode of the MAPS Canada Podcast, Osheen Dayal and Luc Briedé-Cooper speak with Dr. Zach Walsh a leading clinical psychologist and researcher at the University of British Columbia

Episode 13: Wisdom From The Psychedelic Underground | with Rachel Harris

April 24th, 2024  |  1 hr 7 mins

In this episode of the MAPS Canada Podcast, Luc Briedé-Cooper speaks with Rachel Harris, the author of "Swimming In The Sacred: Wisdom from the Psychedelic Underground"

Episode 12: You Had a Mystical Experience - Now What? | Podcast With Michael Phillip

December 6th, 2023  |  58 mins 41 secs

In this episode of the MAPS Canada Podcast, our co-host Sébastien Clermont speaks with Michael Phillip, the creator of Third Eye Drops.

Episode 11: A Christian Minister Took Psychedelics, This Happened | Podcast with Don Lattin

October 4th, 2023  |  56 mins 34 secs

christian psychedelics, christianity, don lattin, nyu john hopkins, psychedelic churches

Listen to this interview with Don Lattin at the Psychedelic Science 2023

Episode 10: The Soap Maker Quietly Leading the Psychedelic Revolution | Podcast with David Bronner

August 2nd, 2023  |  19 mins 54 secs

consciousness, david bronner, drug policy, education, healing, legalization, neuroscience, plant medicine, psychedelic science, psychedelic science 2023, psychotherapy, ptsd, trauma

Listen to this interview with David Bronner at the Psychedlic Science 2023

Episode 9: Why You May Soon Have a Local MDMA Clinic | Podcast with Rick Doblin

May 31st, 2023  |  1 hr 1 min

maps, mdma therapy, psychedelic history, psychedelic science 2023, rick doblin

Watch this interview with Rick Doblin on new results from the MAPS Phase III clinical trials for MDMA assisted therapy